跳转至内容
Merck
CN

G006151

UHPLC/MS Analysis of Antineoplastic and Antidepressant Drugs in Plasma on Titan C18 after SPE using HybridSPE®-PLus

application for HPLC, application for SPE

登录查看公司和协议定价


About This Item

技术

HPLC: suitable
solid phase extraction (SPE): suitable

试验参数

sample/matrix: rat plasma
SPE well plate: HybridSPE-PLus 96-Well Plate, 50 mg/2 mL per well (575659-U)
sample preparation: final analyte concentration 50 ng/mL
sample addition: 400 μL of 1% formic acid acetonitile:spiked plasma (3:1) per well
column: Titan C18, 5 cm x 2.1 mm I.D., 1.9 μm particles (577122-U)
mobile phase: [A] 5 mM ammonium formate; [B] 5 mM ammonium formate in 90:10 (v:v) acetonitrile:water
gradient: 35 to 90% B in 1.5 min, held at 90% B for 0.4 min
flow rate: 0.4 mL/min
pressure: 3582 psi (247 bar)
column temp.: 35 °C
detector: TOF/MS
injection: 1 μL

适用性

application for HPLC
application for SPE

应用

pharmaceutical (small molecule)

分析说明

HybridSPE-Phospholipid plates removed plasma-derived proteins and phospholipids to maximize LC/MS sensitivity. Titan C18 U/HPLC columns provided rapid resolution. The highest grade LC-MS solvents were used to supply low background interference and low particulate contaminants for robust, trouble-free operation. Cerilliant CRMs provided reliable identification and quantification.

法律信息

HybridSPE is a registered trademark of Merck KGaA, Darmstadt, Germany

分析物

说明

    Fluoxetine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
    Tamoxifen, ≥99%

Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门